(E)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol, 97%, 1g

(6-Bromo-2-methyl-pyridin-3-yl)-methanol, 95%, 1g

TERT-BUTYL N-[(4-TERT-BUTYLPHENYL)(CYANO)METHYL]CARBAMATE, 95.0%, 100mg

1-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)-1H-pyrazole, 97%, 100mg

1-Iodo-2-(2-methoxyethoxy)ethane, 95.0%, 1g

4-Dimethylaminoazobenzene-4'-carboxylic acid, 95.0%, 5g

Periodato di potassio, minimo 99,8%, pa, ACS, 500 g, confezione in plastica.

1-Cyclohexylpiperidine-4-carboxylic acid hydrochloride, 97.0%, 1g

Colonna capillare per GC ROTI®Cap-1, 30 m, 0.25 mm, 1.00 µm, 1 Pezzo(i)

2-(2-Pyridinyl)-1H-indole, 95.0%, 5g

Na-Boc-Nb-Azido-D-2,3-diaminopropionic acid cyclohexylammonium salt, 99.0%, 5g

4-(Difluoromethoxy)benzonitrile, 98.0%, 5g

(1-Fluorocyclopropyl)methanamine hydrochloride, 95%, 500mg